Hundreds of children and adults with rare forms of cystic fibrosis in England will be able to access “life-changing” new ‘triple-combination’ therapy for the very first time, the NHS has announced.

Latest studies show Us pharma giant Vertex's new CF wonder pill Alyftrek has shown better results than their currently ...